Institut De Cancérologie De Lorraine
Clinical trials sponsored by Institut De Cancérologie De Lorraine, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Blood test may predict cancer recurrence in head and neck patients Results expected Sep 2026 (estimated)
- Study tests if lowering beeping alarms eases brain strain for trainee surgeons Results expected Jan 2027 (estimated)
- Hypnosis app aims to tame hot flashes for breast cancer patients Results expected Apr 2027 (estimated)
- Could less radiation be just as good for bone cancer pain? Results expected Jul 2027 (estimated)
- Hearing aids tested to ease chemotherapy side effect Results expected Sep 2027 (estimated)
-
New combo therapy shows promise for tough pancreatic cancers
Disease control CompletedThis study tested two different treatment plans for people with a specific type of pancreatic cancer that is on the edge of being removable by surgery. 130 patients received either chemotherapy alone or chemotherapy plus radiation before surgery. The goal was to see which approac…
Phase 2 • Sponsor: Institut de Cancérologie de Lorraine • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a higher radiation dose beat cervical cancer without more harm?
Disease control CompletedThis trial tests whether giving a higher radiation dose during brachytherapy, a type of internal radiation, can improve local control in patients with locally advanced cervical cancer. Participants receive standard external beam radiation and chemotherapy, plus a boosted brachyth…
Phase 2 • Sponsor: Institut de Cancérologie de Lorraine • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New microscope could spot leftover cancer in minutes during surgery
Diagnosis CompletedThis study tests a special microscope that lets doctors check if all cancer cells have been removed during surgery for common skin cancers. About 42 adults with head, neck, or skin cancer will take part. The goal is to see if this quick method is as accurate as the standard lab t…
Sponsor: Institut de Cancérologie de Lorraine • Aim: Diagnosis
Last updated Sep 03, 2026 00:00 UTC
-
A simple dye might replace radioactive tracers in cancer staging
Diagnosis CompletedThis trial tests whether indocyanine green, a dye injected before surgery, can find sentinel lymph nodes as reliably as the standard technetium-99 radioactive tracer. About 744 adults with various cancers will receive both agents, and surgeons will compare detection rates using a…
Phase 3 • Sponsor: Institut de Cancérologie de Lorraine • Aim: Diagnosis
Last updated Sep 03, 2026 00:00 UTC
-
Blood test may reveal hidden cancer cells in head and neck tumors
Diagnosis CompletedThis trial investigates whether a blood test can detect circulating tumor cells (CTCs) in patients with advanced head and neck cancer. Researchers will take blood samples before, during, and after surgery, and use two different methods to count these cells. The goal is to see if …
Sponsor: Institut de Cancérologie de Lorraine • Aim: Diagnosis
Last updated Sep 03, 2026 00:00 UTC
-
Hypnosis eases cancer procedure anxiety, small trial suggests
Symptom relief CompletedThis completed Phase 2 trial tested whether formal hypnosis, alongside standard care, could reduce anxiety and pain in 68 cancer patients undergoing brachytherapy. Patients received either standard care with Kalinox or standard care plus formal hypnosis. The study measured anxiet…
Phase 2 • Sponsor: Institut de Cancérologie de Lorraine • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Can meditation ease stress for cancer care workers?
Symptom relief CompletedThis study tested a 3-session program combining meditation and acceptance and commitment therapy for staff at a cancer center. Twenty employees participated, and researchers measured how many completed the program and their satisfaction. The goal was to see if the program is feas…
Sponsor: Institut de Cancérologie de Lorraine • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Full or empty bladder? study tests best way to protect organs during cervical cancer radiation
Knowledge-focused CompletedThis study looked at 22 women with cervical cancer to see if having an empty bladder (using a catheter) or a full bladder (filled with 120cc of fluid) is better during a type of internal radiation called brachytherapy. The goal was to find which method lowers the radiation dose t…
Sponsor: Institut de Cancérologie de Lorraine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Pill-Taking habits under the microscope in advanced cancer patients
Knowledge-focused CompletedThis study looked at how closely 200 adults with advanced breast or prostate cancer follow their prescribed oral cancer treatments. Participants filled out questionnaires about their medication use and gave blood samples to check certain health markers. The goal was to understand…
Sponsor: Institut de Cancérologie de Lorraine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New device could spot failed pain blocks during mastectomy
Knowledge-focused CompletedThis study looked at 100 women having a mastectomy to see if a device called the Analgesia Nociception Index (ANI) can detect when a nerve block isn't working. The device measures pain signals during general anesthesia. If it works, doctors could adjust pain treatment right away,…
Sponsor: Institut de Cancérologie de Lorraine • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Cancer patients skip exercise – researchers want to know why
Knowledge-focused CompletedThis completed study looked at 261 French cancer patients to understand why many do not exercise, despite evidence that physical activity improves survival and well-being. Researchers surveyed patients about their personality, motivation, anxiety, and social background. The goal …
Sponsor: Institut de Cancérologie de Lorraine • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:16 UTC